AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering
IRVINE, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) — AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused […]
Immix Biopharma Accelerates Enrollment in U.S. AL Amyloidosis Trial of NXC-201 CAR-T
Successfully dosed 6 patients in safety run-in segment, now accelerating enrollment Positive data from first four patients announced December 2024 […]
NEO Battery Materials Unveils Breakthrough Silicon Battery Capacity, Expanding to Space Industry with Solid-State Batteries
New High-Performance Silicon Anode Product Line: NBMSiDE® P-300 Breakthrough 43% to 130% Improvement in Initial Battery Capacity Compared to Traditional […]
Verizon shatters speed barriers with 5.5 Gbps breakthrough
BASKING RIDGE, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) — When customers choose Verizon—they’re not just choosing a network, but a […]
Clearmind Medicine Announces Shareholders Meeting Results
Vancouver, Canada, Jan. 07, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a […]
SEALSQ and WISeSat Unite to Launch Six New Generation Satellites in 2025 Equipped with Advanced Post-Quantum Technology
Geneva, Switzerland, Jan. 07, 2025 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company specializing in Semiconductors, […]
VCI Global Announces IPO for Wholly Owned Consulting Arm, Unlocking New Growth Opportunities
KUALA LUMPUR, Malaysia, Jan. 07, 2025 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global,” or the “Company”), today […]
Renovaro Issues Shareholder Letter and Provides Corporate Update
Company to Host International Roadshow the Week of January 13, 2025 LOS ANGELES, Jan. 07, 2025 (GLOBE NEWSWIRE) — Renovaro […]
Anaptys to Present at the 43rd Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Jan. 07, 2025 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative […]
Renovaro Appoints Nathen Fuentes as Chief Financial Officer
Senior Biotechnology and Specialty Healthcare Financial Executive Brings Extensive Experience in Leading Acquisition and Organic Growth Initiatives LOS ANGELES, Jan. […]
